290 results
Page 3 of 15
8-K
EX-10.2
n1subq86 1c
11 Dec 20
Lexicon Announces Offering of Common Stock
5:28pm
8-K
EX-99.2
4uznnx5ri22vj5
11 Dec 20
Lexicon Announces Offering of Common Stock
5:28pm
424B5
0oqtkhbh rab73o
11 Dec 20
Prospectus supplement for primary offering
8:02am
424B5
zbmfzstm 8b
30 Oct 20
Prospectus supplement for primary offering
5:11pm
8-K
EX-10.1
hh6fdnpqq 59
22 Oct 20
Entry into a Material Definitive Agreement
7:12am
8-K
EX-2.1
oima1z6yvpg3rbpse6
11 Sep 20
Lexicon Pharmaceuticals Completes the Sale of Xermelo to
4:11pm
8-K
EX-99.1
p9vcrmk0sy13zl3yv
30 Jul 20
Lexicon Pharmaceuticals Enters into Agreement
7:18am
8-K
EX-10.1
2za7ovx0tpeyq xrzuw
15 Jul 20
Entry into a Material Definitive Agreement
5:06pm
DEFA14A
5mq 5o4cjoykar6b
13 Mar 20
Additional proxy soliciting materials
7:10am
8-K
EX-10.1
nob44tnxus
16 Jan 20
Entry into a Material Definitive Agreement
4:11pm
8-K
s4i6tib1lp
29 Jul 19
Lexicon Pharmaceuticals Provides Preliminary Update for Zynquistatm (Sotagliflozin) Type 2 Diabetes Phase 3 Program
12:00am